CLGN — Collplant Biotechnologies Cashflow Statement
0.000.00%
Last trade - 00:00- $29.50m
- $18.07m
- $0.52m
Annual cashflow statement for Collplant Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.77 | 0.237 | -16.9 | -7.02 | -16.6 |
| Depreciation | |||||
| Non-Cash Items | 1.79 | 1.27 | 2.69 | 2.33 | 1.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.12 | 0.216 | -0.544 | 0.82 | -0.372 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.45 | 2.5 | -13.7 | -2.76 | -14.1 |
| Capital Expenditures | -0.519 | -1.59 | -1.32 | -0.954 | -0.483 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -30 | 30.2 | -0.202 | -0.056 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.519 | -31.6 | 28.9 | -1.16 | -0.539 |
| Financing Cash Flow Items | — | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.46 | 38.8 | 1.87 | 1.11 | 0.009 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.445 | 9.85 | 16.5 | -3.19 | -14.8 |